Published in Int Arch Allergy Appl Immunol on January 01, 1984
Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun (1992) 3.85
Kinetics and characterization of interferon production by murine spleen cells stimulated with Legionella pneumophila antigens. Infect Immun (1985) 0.95
Vaccination with Legionella pneumophila membranes induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. Protective immunity independent of the major secretory protein of Legionella pneumophila. J Clin Invest (1991) 0.95
Macrophage-activating T-cell factor(s) produced in an early phase of Legionella pneumophila infection in guinea pigs. Infect Immun (1989) 0.87
Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila. J Clin Microbiol (1979) 15.15
Primary isolation media for Legionnaires disease bacterium. J Clin Microbiol (1978) 11.86
Pittsburgh pneumonia agent: direct isolation from human lung tissue. J Infect Dis (1980) 11.36
A revision of the Trauma Score. J Trauma (1989) 9.31
Proposed diagnostic criteria for neurocysticercosis. Neurology (2001) 9.15
Plasmid-mediated tissue invasiveness in Yersinia enterocolitica. Nature (1980) 8.15
Isolation of the Legionnaires' disease bacterium from environmental samples. Ann Intern Med (1979) 7.69
Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol (1983) 6.86
Cholera--a possible endemic focus in the United States. N Engl J Med (1980) 6.71
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
India ink staining of proteins on nitrocellulose paper. Anal Biochem (1983) 5.78
Epidemic Yersinia enterocolitica infection due to contaminated chocolate milk. N Engl J Med (1978) 5.39
Detection of antibodies to legionnaires disease organism by microagglutination and micro-enzyme-linked immunosorbent assay tests. J Clin Microbiol (1978) 4.45
Evaluation of a dispensing instrument (Dynatech MIC-2000) for preparing microtiter antibiotic plates and testing their potency during storage. Antimicrob Agents Chemother (1978) 4.37
Legionella gormanii sp. nov. J Clin Microbiol (1980) 4.12
Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera. J Clin Invest (1968) 3.72
A case of cholera in Texas, 1973. Am J Epidemiol (1974) 3.71
Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34
Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10. J Infect Dis (1985) 3.16
Evidence for two distinct types of penicillinase-producing Neisseria gonorrhoeae. Lancet (1977) 3.09
Proliferation of Legionella pneumophila as an intracellular parasite of the ciliated protozoan Tetrahymena pyriformis. Appl Environ Microbiol (1984) 3.02
"Endotoxicity" of the Legionnaires' disease bacterium. Ann Intern Med (1979) 2.78
Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine. Ann Intern Med (1979) 2.76
Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG) Lancet (1993) 2.66
Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci (1996) 2.57
Detection of Legionella pneumonophila antigen in urine by enzyme-linked immunospecific assay. J Clin Microbiol (1979) 2.54
Isolation of protozoa from water associated with a legionellosis outbreak and demonstration of intracellular multiplication of Legionella pneumophila. Appl Environ Microbiol (1986) 2.52
Cholera on Guam, 1974: epidemiologic findings and isolation of non-toxinogenic strains. Am J Epidemiol (1977) 2.46
DNP-Lys-ficoll: a T-independent antigen which elicits both IgM and IgG anti-DNP antibody-secreting cells. J Immunol (1975) 2.40
Epidemiologic study of a fatal case of inhalation anthrax. Arch Environ Health (1969) 2.39
Evaluation of the microenzyme-linked immunosorbent assay with Treponema pallidum antigen. J Clin Microbiol (1982) 2.35
Virulence and phenotypic characterization of Yersinia enterocolitica isolated from humans in the United States. J Clin Microbiol (1983) 2.32
Comparison of guinea pig and protozoan models for determining virulence of Legionella species. Infect Immun (1986) 2.28
Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease. Lancet (1978) 2.28
Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr (1975) 2.21
Isolation of Vi antigen and a simple method for its measurement. Appl Microbiol (1972) 2.20
Identification of problem Neisseria gonorrhoeae cultures by standard and experimental tests. J Clin Microbiol (1982) 2.17
A major focus of Legionnaires' disease in Bloomington, Indiana. Ann Intern Med (1979) 2.16
Standardization and control of meningococcal vaccines, group A and group C polysaccharides. J Biol Stand (1977) 2.11
A simultaneous outbreak of meningococcal and influenza infections. N Engl J Med (1972) 2.11
Cellular requirements for the primary in vitro antibody response to DNP-ficoll. J Exp Med (1974) 2.10
Titration of cholera antitoxin levels by passive hemagglutination tests using fresh and formalinized sheep erythrocytes. Proc Soc Exp Biol Med (1970) 2.10
Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents. Antimicrob Agents Chemother (1981) 2.10
Characteristics of non-cholera Vibrios isolated from cases of human diarrhoea. Bull World Health Organ (1965) 2.09
Isolation of Listeria monocytogenes from raw milk. Appl Environ Microbiol (1986) 2.04
Tuberculin sensitivity testing and treatment of latent tuberculosis remains effective for tuberculosis control in human immunodeficiency virus-infected patients in Hong Kong. Hong Kong Med J (2013) 2.02
Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. I. Study design and results of the first year of observation. Bull World Health Organ (1969) 2.00
Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis (1991) 1.95
Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. J Nucl Med (1997) 1.92
Evaluation of a new assay for Vi antibody in chronic carriers of Salmonella typhi. J Clin Microbiol (1980) 1.90
Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg (1990) 1.88
Biochemistry of Vibrio cholerae Virulence I. Purification and Biochemical Properties of PF/Cholera Enterotoxin. Infect Immun (1970) 1.87
A new characterization of injury severity. J Trauma (1990) 1.86
Cyclophosphamide in the treatment of systemic lupus erythematosus. Br Med J (1966) 1.83
Multiple serotypes of vibrio cholerae isolated from a case of cholera. Evidence suggesting in-vivo mutation. Lancet (1967) 1.83
Pontiac fever: isolation of the etiologic agent (Legionella pneumophilia) and demonstration of its mode of transmission. Am J Epidemiol (1981) 1.77
Tetanus and diphtheria immunity in an elderly population in Los Angeles County. Am J Public Health (1983) 1.77
Sodium desoxycholate-extracted treponemal antigen in an enzyme-linked immunosorbent assay for syphilis. J Clin Microbiol (1982) 1.75
Toluidine red unheated serum test, a nontreponemal test for syphilis. J Clin Microbiol (1983) 1.74
Quantitative, single-tube, kinetic-dependent enzyme-linked immunosorbent assay (k-ELISA). Methods Enzymol (1983) 1.72
Lyme disease: a selective medium for isolation of the suspected etiological agent, a spirochete. J Clin Microbiol (1984) 1.72
Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. J Clin Microbiol (1984) 1.70
Human disease caused by Brucella canis. A clinical and epidemiologic study of two cases. JAMA (1975) 1.69
The effect of two chlorinated lincomycin analogues against acute toxoplasmosis in mice. Am J Trop Med Hyg (1973) 1.66
Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis (1999) 1.63
Demonstration of species-specific and cross-reactive components of the adult microsomal antigens from Schistosoma mansoni and S. japonicum (MAMA and JAMA). J Immunol (1984) 1.63
Diagnosis of cysticercosis in endemic regions. The Cysticercosis Working Group in Peru. Lancet (1991) 1.63
Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002. HIV Med (2006) 1.61
Legionellosis. Am J Pathol (1981) 1.59
Immunoglobulin specificity for the fluorescent treponemal antibody-absorption test conjugate. J Clin Microbiol (1976) 1.58
Salmonella excretion by turtles. Public Health Rep (1967) 1.57
Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes. Appl Microbiol (1970) 1.55
Enzyme-linked immunosorbent assay for detection of Salmonella typhi Vi antigen in urine from typhoid patients. J Clin Microbiol (1982) 1.55
Immunodiagnosis of human cysticercosis (Taenia solium): a field comparison of an antibody-enzyme-linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. The Cysticercosis Working Group in Peru (CWG). Am J Trop Med Hyg (1992) 1.53
Nuclease enhancement of specific cell agglutination in a serodiagnostic test for Neisseria gonorrhoeae. J Clin Microbiol (1979) 1.53
Immunologic factors affecting the in-vivo and in-vitro survival of the Legionnaires' disease bacterium. Ann Intern Med (1979) 1.53
Immunological conversion of Vibrio chorlerae in gnotobiotic mice. Infect Immun (1972) 1.52
Absolute quantification of regional myocardial uptake of 99mTc-sestamibi with SPECT: experimental validation in a porcine model. J Nucl Med (2001) 1.52
Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence. Am J Trop Med Hyg (2001) 1.52
Progress in characterizing anatomic injury. J Trauma (1990) 1.48
Urethritis in women attending an STD clinic. Br J Vener Dis (1981) 1.48
The transfer of allergic thyroiditis in histocompatible guinea pigs by lymph node cells. J Immunol (1967) 1.48
Tularemia epidemia: Vermont, 1968. Forty-seven cases linked to contact with muskrats. N Engl J Med (1969) 1.47
Upper limit of normal titer for detection of antibodies to Legionella pneumophila by the microagglutination test. J Clin Microbiol (1979) 1.45
Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. J Clin Microbiol (2001) 1.44
Immunological and serological diversity of Neisseria gonorrhoeae: immunotyping of gonococci by cross-protein in guinea pig subcutaneous chambers. Infect Immun (1976) 1.42
The microbiology and therapy of acute pelvic inflammatory disease in hospitalized patients. Am J Obstet Gynecol (1980) 1.42
Schistosomiasis in Lake Malawi. Lancet (1996) 1.42
A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg (1998) 1.41
Legionella anisa: a new species of Legionella isolated from potable waters and a cooling tower. Appl Environ Microbiol (1985) 1.41
Vi serology in the detection of typhoid carriers. Lancet (1981) 1.39
Treatment outcomes after early initiation of antiretroviral therapy for human immunodeficiency virus-associated tuberculosis. Hong Kong Med J (2013) 1.39
Epilepsy and neurocysticercosis in an Andean community. Int J Epidemiol (1999) 1.38
Antibiotic susceptibility of clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother (1978) 1.38